By University of Missouri School of Medicine –
There may be a way to slow the growth of endometrial cancer through targeted cancer cell therapy, according to new research from the University of Missouri School of Medicine.
This year, around 65,000 women are expected to be diagnosed with endometrial cancer, the most common cancer of the female reproductive organs. An increased risk in development for multiple human cancers is associated with mutations in the PTEN protein, which normally regulates cell division and growth. The mutation allows cells to multiply uncontrollably.
Mice models demonstrate how suppressing a specific protein expression can decrease tumor growth.
